Daniel DeSalvo, MD
Director of Strategic Collaboration, Texas Children’s Diabetes & Endocrine Care Center, Texas Children’s Hospital
Type 1 Diabetes Clinic Lead, Texas Children’s Hospital
Diabetes Transition Clinic Co-Lead, Texas Children’s Hospital
Assistant Professor, Baylor College of Medicine
Daniel DeSalvo joined the Texas Children’s Hospital Section of Pediatric Diabetes and Endocrinology in July 2015 after completing a postdoctoral fellowship at Stanford University. He serves as the Type 1 Diabetes Clinic Lead, Director of Strategic Collaboration for the Texas Children’s Diabetes & Endocrine Care Center, and TCH Diabetes Transition Clinic Co-Lead. His overarching career goal as a pediatric endocrinologist is to provide compassionate and comprehensive care to youth with diabetes, and to advance clinical care through patient-centered research and quality improvement endeavors. His clinical and research focus is on emerging diabetes technology and therapies (including continuous glucose monitoring and closed-loop automated insulin delivery systems) for improving clinical outcomes and reducing the burden of care. It was through his personal experience living with type 1 diabetes, and a desire to help others on a similar journey that motivated him to become a pediatric endocrinologist.